In patients with NASH and fibrosis, the density of C5aR1-positive cells (HSCs and macrophages) is 2–3 times higher than in patients with simple fatty liver, suggesting that the activity of the C5a-C5aR1 pathway is closely related to disease progression. This evidence concerns the gene C5AR1 and metabolic dysfunction-associated steatohepatitis.